A Proof of Concept Study to Investigate the Effect of IPT803 Adjunct Treatment in Patients With Parkinson's Disease
Phase of Trial: Phase I/II
Latest Information Update: 27 Dec 2018
At a glance
- Drugs IPT-803 (Primary)
- Indications Parkinson's disease
- Focus Proof of concept; Therapeutic Use
- Sponsors Tools4Patient
- 20 Dec 2018 Planned number of patients changed from 144 to 120.
- 05 Sep 2018 Status changed from not yet recruiting to recruiting.
- 30 May 2018 Planned End Date changed from 1 Sep 2019 to 1 Oct 2019.